The phrase "adherence treatment" is not commonly used in written English and may cause confusion.
It could be used in a medical or psychological context to refer to treatment strategies aimed at ensuring patients follow prescribed therapies or medications.
Example: "The clinic focuses on adherence treatment to improve patient outcomes and ensure that individuals stick to their medication regimens."
Alternatives: "compliance therapy" or "medication adherence strategy".
The negative impacts of food insecurity on ARV adherence, treatment continuation, HIV RNA suppression, and mortality argue for the need to incorporate food supplementation and sustainable food production strategies as essential components of emerging ARV treatment programs.
We examined the temporal association between average adherence, treatment interruptions and subsequent viral rebound in all subjects, but in particular, subjects with <80% adherence because they are at highest risk for virologic rebound[7], [10].
Besides encouraging ARV adherence, treatment partners contribute to the social health of patients.
Descriptive statistics are reported for patient demographics, disease characteristics, treatment adherence, treatment discontinuation, reasons for RLAI initiation, RLAI dose, antipsychotic and other concomitant medications, and adverse events.
A secondary aim was to test the prognostic value of illness severity, adherence, treatment credibility and the influence of having a family history of social anxiety.
As well as adherence, treatment persistence is an important factor for any first-line injectable therapy if patients are to benefit from early intervention.
These impossible choices caused significant anxiety for many individuals in our study; in some cases, they also contributed to ARV non-adherence, treatment interruptions, and fears about HAART initiation.
When the number of medicines was taken as a between-subjects factor, only intentional non-adherence, treatment necessity beliefs, and perceptions of illness timeline were accounted for.
A principal challenge is duration usually no less than 6 months—of chemotherapy, which contributes to non-adherence, treatment failure, and if not completed the acquisition of anti-tuberculosis drug resistance [ 1- 3].
Insufficient adherence to treatment can lead to unmet treatment expectations resulting in inadequate disease control [2] [5].
